Cai and colleagues reported that PKCα increases Gli1 activity via MEK/ERK pathway and PKCδ negatively regulates Gli1 expression through transcriptional down-regulation of GLI1 mRNA in NIH/3T3 cells and human Hepatoma Hep3B Cells [56]. Here, GLI1 is linked to hepatocellular carcinoma.